GHSI Stock Overview
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Guardion Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.15 |
| 52 Week High | US$10.75 |
| 52 Week Low | US$5.01 |
| Beta | 0.88 |
| 1 Month Change | -9.65% |
| 3 Month Change | 42.98% |
| 1 Year Change | 35.16% |
| 3 Year Change | -90.89% |
| 5 Year Change | -98.72% |
| Change since IPO | -99.26% |
Recent News & Updates
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Apr 10
Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward
Feb 06Recent updates
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Apr 10Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward
Feb 06Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues
Apr 17Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67M
Aug 11Guardion Health closes Activ Nutritional acquisition
Jun 02Guardion Health initiates GlaucoCetin glaucoma trial
May 03The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More
Jan 15Guardion Health names industry veteran Bret Scholtes as new president and CEO
Dec 28Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?
Nov 24
Shareholder Returns
| GHSI | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 1.2% | -0.5% | 1.0% |
| 1Y | 35.2% | -28.8% | 21.9% |
Return vs Industry: GHSI exceeded the US Personal Products industry which returned -26% over the past year.
Return vs Market: GHSI exceeded the US Market which returned 24.9% over the past year.
Price Volatility
| GHSI volatility | |
|---|---|
| GHSI Average Weekly Movement | 19.7% |
| Personal Products Industry Average Movement | 8.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GHSI's share price has been volatile over the past 3 months.
Volatility Over Time: GHSI's weekly volatility has increased from 12% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 9 | Jan Hall | www.guardionhealth.com |
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement.
Guardion Health Sciences, Inc. Fundamentals Summary
| GHSI fundamental statistics | |
|---|---|
| Market cap | US$10.47m |
| Earnings (TTM) | US$158.03k |
| Revenue (TTM) | US$12.25m |
66.2x
P/E Ratio0.9x
P/S RatioIs GHSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GHSI income statement (TTM) | |
|---|---|
| Revenue | US$12.25m |
| Cost of Revenue | US$6.85m |
| Gross Profit | US$5.39m |
| Other Expenses | US$5.24m |
| Earnings | US$158.03k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 44.04% |
| Net Profit Margin | 1.29% |
| Debt/Equity Ratio | 0% |
How did GHSI perform over the long term?
See historical performance and comparison